We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
75 hedge funds and large institutions have $16.3M invested in Madrigal Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
44% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 84 → 75 (-9)
39% less call options, than puts
Call options by funds: $79K | Put options by funds: $130K
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
86% less capital invested
Capital invested by funds: $119M → $16.3M (-$103M)
Holders
75
Holders Change
-9
Holders Change %
-10.71%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
26
Reduced
18
Closed
22
Calls
$79K
Puts
$130K
Net Calls
-$51K
Net Calls Change
+$238K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.96M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$953K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$776K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$694K |
| 5 |
Goldman Sachs
New York
|
+$633K |
Top Sellers
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$12.1M |
| 2 |
Jennison Associates
New York
|
-$11.5M |
| 3 |
AC
Armistice Capital
New York
|
-$3.48M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.57M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.46M |
